Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

RNMTL1 Inhibitors

RNMTL1 inhibitors represent a chemical class targeting the enzyme RNMTL1 (RNA Methyltransferase Like 1), an enzyme involved in the methylation of RNA. Methylation of RNA is a critical post-transcriptional modification that plays a significant role in regulating RNA stability, localization, and translation efficiency. RNMTL1 specifically catalyzes the addition of methyl groups to nucleotides, influencing various cellular processes related to RNA metabolism. The inhibition of RNMTL1 disrupts these processes, making this chemical class essential for probing the mechanistic aspects of RNA modification pathways. By targeting RNMTL1, researchers can explore the role of RNA methylation in gene expression regulation and RNA-protein interactions, offering a deeper understanding of the biochemical pathways influencing RNA behavior within the cell.

These inhibitors are typically designed to bind to the active site of RNMTL1, obstructing its catalytic function. Structurally, RNMTL1 inhibitors may exhibit various scaffolds and functional groups optimized for interaction with the enzyme's active site residues, including polar interactions, hydrogen bonding, and van der Waals forces. The development of these inhibitors is often driven by the need to map the enzyme's structure-function relationships and to characterize the impact of RNA methylation in cellular models. The use of RNMTL1 inhibitors allows for the exploration of RNA post-transcriptional modifications in a controlled setting, aiding in the discovery of how methylation patterns affect RNA fate and the cellular outcomes of these modifications. This chemical class remains a valuable tool for biochemical research, particularly in understanding RNA epigenetics and enzymatic regulation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

Inhibits DNA methyltransferases, leading to reduced methylation, which can indirectly affect RNA methylation patterns regulated by proteins like RNMTL1.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Hypomethylating agent that targets DNA methylation, potentially influencing RNA methylation and the cellular context of RNMTL1.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

Non-nucleoside DNA methyltransferase inhibitor, altering global methylation status, and could affect the methylation landscape where RNMTL1 is active.

Homocysteine

6027-13-0sc-507315
250 mg
$195.00
(0)

Product inhibitor of methyltransferases, could reduce the methyltransferase activity of RNMTL1 by increasing the levels of this competitive inhibitor.

Adenosine, periodate oxidized

34240-05-6sc-214510
sc-214510A
25 mg
100 mg
$119.00
$364.00
(0)

Inhibits S-adenosyl-L-homocysteine hydrolase, leading to the accumulation of S-Adenosylhomocysteine, which can inhibit RNMTL1.

BIX01294 hydrochloride

1392399-03-9sc-293525
sc-293525A
sc-293525B
1 mg
5 mg
25 mg
$37.00
$112.00
$408.00
(1)

Inhibitor of G9a histone methyltransferase, could indirectly affect chromatin structure and the transcriptional regulation of RNMTL1.

Chaetocin

28097-03-2sc-200893
200 µg
$126.00
5
(1)

Inhibits histone methyltransferases, potentially altering transcriptional regulation and influencing RNMTL1's activity.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Antitumor antibiotic that binds to DNA, potentially affecting gene expression and indirectly modifying RNMTL1 activity.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

Histone deacetylase inhibitor, may influence chromatin remodeling and indirectly affect RNMTL1's interaction with RNA substrates.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Flavonoid that has been shown to inhibit a variety of kinases, potentially altering signaling pathways that regulate RNMTL1.